News Conference News ESC 2016 Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4 Todd Neale August 31, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients Todd Neale July 29, 2016
News Daily News Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia L.A. McKeown July 19, 2016
News Daily News Sigue Abusándose de la Aspirina como Protección Única frente a los ACV en Pacientes con FA Todd Neale June 27, 2016
News Daily News Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib Todd Neale June 27, 2016
News Daily News ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients L.A. McKeown April 29, 2014